<DOC>
	<DOCNO>NCT01185756</DOCNO>
	<brief_summary>The aim study assess cardiac innervation patient heart failure well select candidate implantable cardioverter defibrillator . Cardiac innervation assess use image agent administer intravenously .</brief_summary>
	<brief_title>MIBG Scintigraphy Tool Selecting Patients Requiring Implantable Cardioverter Defibrillator ( ICD )</brief_title>
	<detailed_description>The survival benefit provide implantable cardioverter defibrillator ( ICD ) primary prevention sudden cardiac death heart failure compare medical treatment alone well establish . First limit severe patient , indication gradually extend accordance result recent study . This beneficial effect term public health accompany increase health spending threatens grow strongly short medium term . However , majority ICDs implant solicit overall low incidence severe ventricular arrhythmia population meeting implantation criterion . To optimize resource , therefore important good ass risk sudden death patient candidate ICD implantation . The overactivation NEURO-humoral system play important role progression heart failure , occurrence ventricular arrhythmia . The iodine-123 meta-iodobenzylguanidine scintigraphy ( MIBG ) , functional imaging method noninvasively evaluate cardiac sympathetic innervation . It show cardiac adrenergic hyperactivation estimate MIBG scintigraphy associate poor outcome , value independent superior prognostic factor heart failure . More importantly , risk occurrence major cardiac event minimal cardiac uptake MIBG high . Furthermore , plasma natriuretic peptide ( particularly BNP NT-proBNP ) , indicator NEURO-hormonal activation use diagnosis assessment prognosis heart failure , predictive risk occurrence sudden death population . In summary , MIBG scintigraphy NT-proBNP two prognostic marker heart failure relate degree NEURO-hormonal dysfunction , good negative predictive value mortality . Their combine use could therefore help identify patient low risk severe arrhythmias.These test currently part heart failure diagnosis patient candidate ICD implantation .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Death , Sudden</mesh_term>
	<mesh_term>3-Iodobenzylguanidine</mesh_term>
	<criteria>Indication ICD primary prevention accord European Society Cardiology guideline Secondary prevention indication ICD Acute coronary syndrome within last 40 day Revascularization procedure ( bypass percutaneous coronary angioplasty ) perform within last 3 month plan Pregnancy lactate female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Sudden death</keyword>
	<keyword>Implantable Cardioverter Defibrillator</keyword>
	<keyword>MIBG scintigraphy</keyword>
</DOC>